{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:08:21Z","timestamp":1761898101196,"version":"3.37.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The objective of this study was to investigate whether an isolated abnormal 1-hour glucose challenge test (GCT) among patients without gestational diabetes (GDM) is associated with adverse outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a retrospective cohort study of patients who underwent GDM screening at \u2265\u200924 weeks\u2019 gestation with a 1-hour GCT and delivered a singleton fetus at &gt;\u200935 weeks\u2019 gestation at an urban tertiary hospital from 1\/2013 to 10\/2021. Data were extracted from an electronic medical record data warehouse using standardized billing\/diagnosis codes. Individuals were categorized into 3 groups: normal screening (1-hour GCT value\u2009&lt;\u2009140\u00a0mg\/dL), intermediate screening (1-hour GCT value \u2265\u2009140 and &lt;\u2009200 but normal 3-hour glucose tolerance test (GTT)), and GDM (1-hour GCT\u2009\u2265\u2009200\u00a0mg\/dL or abnormal 3-hour GTT). The primary composite perinatal morbidity outcome included any of the following: large for gestational age (LGA) birthweight, birth injury, hypoglycemia with neonatal intensive care unit (NICU) admission, respiratory distress syndrome, transient tachypnea of the newborn, apnea, NICU admission, or perinatal death. Multiple secondary outcomes were also evaluated. Bivariable analyses and multivariable logistic regression modeling were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 37,277 eligible patients, 29,698 (79.7%) had normal screening results, 5092 (13.7%) had intermediate screening results, and 2487 (6.6%) were diagnosed with GDM. There were significant differences in baseline characteristics between the three groups, including age, parity, race and ethnicity, payer-type, obesity, and pre-pregnancy metformin use. Compared to normal screening, intermediate screening was associated with an increased risk for the composite perinatal morbidity outcome (OR 1.23, 95% CI 1.15\u20131.32), cesarean (OR 1.37, 95% CI 1.28\u20131.46), and hypertensive disorders of pregnancy (OR 1.30, 95% CI 1.20\u20131.40). Associations for these outcomes were further pronounced in those with GDM compared to normal screening (OR 1.86, 95% CI 1.70\u20132.03; OR 1.69, 95% CI 1.56\u20131.84; and OR 1.57, 95% CI 1.42\u20131.74, respectively). After adjusting for potential confounders, increased risks for the composite perinatal morbidity outcome persisted for those with intermediate screening (aOR 1.18, 95% CI 1.10\u20131.26).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In addition to patients with GDM, individuals an isolated abnormal 1-hour GCT without GDM were also at increased risks for adverse pregnancy outcomes. Further investigation is needed to understand if patients with mild dysregulation may still benefit from other interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07214-x","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:46:12Z","timestamp":1739292372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between isolated abnormal 1-hour glucose challenge test and adverse pregnancy outcomes: a retrospective review from an urban tertiary care center in the United States"],"prefix":"10.1186","volume":"25","author":[{"given":"Hillary","family":"Hosier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisbet S.","family":"Lundsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Culhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moeun","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"7214_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diabres.2018.05.010","volume":"141","author":"SS Casagrande","year":"2018","unstructured":"Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women. Diabetes Res Clin Pract. 2018;141:200\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"7214_CR2","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"ACOG Practice Bulletin No","year":"2018","unstructured":"ACOG Practice Bulletin No. 190: gestational diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49\u201364.","journal-title":"Obstet Gynecol"},{"issue":"19","key":"7214_CR3","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"HSCR Group","year":"2008","unstructured":"Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","journal-title":"N Engl J Med"},{"issue":"5","key":"7214_CR4","doi-asserted-by":"publisher","first-page":"e4401","DOI":"10.1016\/j.ajog.2013.06.044","volume":"209","author":"TA Hillier","year":"2013","unstructured":"Hillier TA, Ogasawara KK, Pedula KL, Vesco KK. Markedly different rates of incident insulin treatment based on universal gestational diabetes mellitus screening in a diverse HMO population. Am J Obstet Gynecol. 2013;209(5):e4401\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"7214_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa042973","volume":"352","author":"CA Crowther","year":"2005","unstructured":"Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477\u201386.","journal-title":"N Engl J Med"},{"issue":"14","key":"7214_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","volume":"361","author":"MB Landon","year":"2009","unstructured":"Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339\u201348.","journal-title":"N Engl J Med"},{"issue":"7","key":"7214_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","volume":"144","author":"MW Carpenter","year":"1982","unstructured":"Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768\u201373.","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"7214_CR8","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"A American Diabetes","year":"2017","unstructured":"American Diabetes A. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl 1):S11\u201324.","journal-title":"Diabetes Care"},{"key":"7214_CR9","doi-asserted-by":"crossref","unstructured":"Aris IM, Kleinman KP, Belfort MB, Kaimal A, Oken E. A 2017 US reference for Singleton Birth Weight Percentiles using Obstetric estimates of Gestation. Pediatrics. 2019;144(1).","DOI":"10.1542\/peds.2019-0076"},{"issue":"1","key":"7214_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","volume":"157","author":"V De Leo","year":"2011","unstructured":"De Leo V, Musacchio MC, Piomboni P, Di Sabatino A, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):63\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"7214_CR11","first-page":"486","volume":"375","author":"C Gyamfi-Bannerman","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA. Antenatal Betamethasone for women at risk for late Preterm Delivery. N Engl J Med. 2016;375(5):486\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"7214_CR12","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44\u201352.","journal-title":"Obstet Gynecol"},{"issue":"24","key":"7214_CR13","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1080\/14767058.2019.1706473","volume":"34","author":"JT Roeckner","year":"2021","unstructured":"Roeckner JT, Bennett S, Mitta M, Sanchez-Ramos L, Kaunitz AM. Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis. J Matern Fetal Neonatal Med. 2021;34(24):4132\u201340.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"7214_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2016.04.040","volume":"215","author":"JT Roeckner","year":"2016","unstructured":"Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, Kaunitz AM. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;215(3):287\u201397.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"7214_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2337\/dc08-0126","volume":"31","author":"R Retnakaran","year":"2008","unstructured":"Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction. Diabetes Care. 2008;31(7):1275\u201381.","journal-title":"Diabetes Care"},{"key":"7214_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2393-8-31","volume":"8","author":"H Ju","year":"2008","unstructured":"Ju H, Rumbold AR, Willson KJ, Crowther CA. Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy Childbirth. 2008;8:31.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"7214_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1479-828X.2007.00743.x","volume":"47","author":"JM Dodd","year":"2007","unstructured":"Dodd JM, Crowther CA, Antoniou G, Baghurst P, Robinson JS. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol. 2007;47(4):307\u201312.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"7214_CR18","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.ajog.2006.01.028","volume":"194","author":"GB McLaughlin","year":"2006","unstructured":"McLaughlin GB, Cheng YW, Caughey AB. Women with one elevated 3-hour glucose tolerance test value: are they at risk for adverse perinatal outcomes? Am J Obstet Gynecol. 2006;194(5):e16\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7214_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0002-9378(95)90183-3","volume":"173","author":"M Sermer","year":"1995","unstructured":"Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-hospital Gestational Diabetes Project. Am J Obstet Gynecol. 1995;173(1):146\u201356.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"7214_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0002-9378(89)90361-X","volume":"161","author":"O Langer","year":"1989","unstructured":"Langer O, Anyaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol. 1989;161(3):593\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"7214_CR21","first-page":"CD011970","volume":"5","author":"J Brown","year":"2017","unstructured":"Brown J, Alwan NA, West J, Brown S, McKinlay CJ, Farrar D, et al. Lifestyle interventions for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;5:CD011970.","journal-title":"Cochrane Database Syst Rev"},{"key":"7214_CR22","first-page":"CD012327","volume":"8","author":"R Martis","year":"2018","unstructured":"Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018;8:CD012327.","journal-title":"Cochrane Database Syst Rev"},{"key":"7214_CR23","doi-asserted-by":"crossref","unstructured":"Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2015(4):CD010443.","DOI":"10.1002\/14651858.CD010443.pub2"},{"key":"7214_CR24","first-page":"CD010443","volume":"11","author":"E Shepherd","year":"2017","unstructured":"Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017;11:CD010443.","journal-title":"Cochrane Database Syst Rev"},{"key":"7214_CR25","first-page":"CD006674","volume":"1","author":"J Tieu","year":"2017","unstructured":"Tieu J, Shepherd E, Middleton P, Crowther CA. Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017;1:CD006674.","journal-title":"Cochrane Database Syst Rev"},{"key":"7214_CR26","first-page":"CD009037","volume":"1","author":"S Han","year":"2012","unstructured":"Han S, Crowther CA, Middleton P. Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria. Cochrane Database Syst Rev. 2012;1:CD009037.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"7214_CR27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1503\/cmaj.111154","volume":"184","author":"R Retnakaran","year":"2012","unstructured":"Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, et al. Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ. 2012;184(12):1353\u201360.","journal-title":"CMAJ"},{"key":"7214_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2393-7-27","volume":"7","author":"JR Moss","year":"2007","unstructured":"Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS. Australian carbohydrate intolerance study in pregnant women G. costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth. 2007;7:27.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"7214_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/10641950903115012","volume":"30","author":"DB Carr","year":"2011","unstructured":"Carr DB, Newton KM, Utzschneider KM, Faulenbach MV, Kahn SE, Easterling TR, et al. Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy. 2011;30(2):153\u201363.","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"7214_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0301-2115(01)00556-5","volume":"102","author":"A Vambergue","year":"2002","unstructured":"Vambergue A, Nuttens MC, Goeusse P, Biausque S, Lepeut M, Fontaine P. Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. Eur J Obstet Gynecol Reprod Biol. 2002;102(1):31\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7214_CR31","doi-asserted-by":"crossref","unstructured":"Abu Shqara R, Or S, Wiener Y, Lowenstein L, Frank Wolf M. Clinical implications of the 100-g oral glucose tolerance test in the third trimester. Arch Gynecol Obstet. 2022.","DOI":"10.1007\/s00404-022-06520-5"},{"issue":"3","key":"7214_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00125-021-05622-0","volume":"65","author":"MA Bochkur Dratver","year":"2022","unstructured":"Bochkur Dratver MA, Arenas J, Thaweethai T, Yu C, James K, Rosenberg EA, et al. Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors. Diabetologia. 2022;65(3):541\u201351.","journal-title":"Diabetologia"},{"issue":"1","key":"7214_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12884-023-05496-7","volume":"23","author":"D Di Filippo","year":"2023","unstructured":"Di Filippo D, Henry A, Bell C, Haynes S, Chang MHY, Darling J, et al. A new continuous glucose monitor for the diagnosis of gestational diabetes mellitus: a pilot study. BMC Pregnancy Childbirth. 2023;23(1):186.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"7214_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ajog.2023.04.021","volume":"229","author":"M Fishel Bartal","year":"2023","unstructured":"Fishel Bartal M, Ashby Cornthwaite J, Ghafir D, Ward C, Nazeer SA, Blackwell SC, et al. Continuous glucose monitoring in individuals undergoing gestational diabetes screening. Am J Obstet Gynecol. 2023;229(4):441. e1- e14.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"7214_CR35","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/jdi.13865","volume":"13","author":"Y Gupta","year":"2022","unstructured":"Gupta Y, Singh C, Goyal A, Mani K, Bharti J, Singhal S, et al. Continuous glucose monitoring system profile of women diagnosed as gestational diabetes mellitus by International Association of Diabetes and pregnancy study groups criteria and labeled as normoglycemic by alternate criteria in early pregnancy. J Diabetes Investig. 2022;13(10):1753\u201360.","journal-title":"J Diabetes Investig"},{"issue":"10","key":"7214_CR36","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","volume":"25","author":"C Kim","year":"2002","unstructured":"Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862\u20138.","journal-title":"Diabetes Care"},{"key":"7214_CR37","doi-asserted-by":"crossref","unstructured":"Echouffo-Tcheugui JB, Guan J, Retnakaran R, Shah BR. Gestational diabetes and Incident Heart failure: a Cohort Study. Diabetes Care. 2021.","DOI":"10.2337\/figshare.14999628.v1"},{"issue":"6","key":"7214_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","volume":"62","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905\u201314.","journal-title":"Diabetologia"},{"issue":"2","key":"7214_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00125-018-4775-z","volume":"62","author":"R Retnakaran","year":"2019","unstructured":"Retnakaran R, Luo J, Shah BR. Gestational diabetes in young women predicts future risk of serious liver disease. Diabetologia. 2019;62(2):306\u201310.","journal-title":"Diabetologia"},{"issue":"3","key":"7214_CR40","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1210\/jc.2008-2434","volume":"94","author":"R Retnakaran","year":"2009","unstructured":"Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J Clin Endocrinol Metab. 2009;94(3):840\u20135.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07214-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:46:17Z","timestamp":1739292377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07214-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7214"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07214-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and experimental protocol were approved by the Yale New Haven Hospital Institutional Review Board (IRB). The need for individual participant informed consent was waived by the Yale IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}